Recombinant Erwinia Asparaginase and Venetoclax in Combination With Blinatumomab for the Treatment of Relapsed or Refractory CD19 Positive B-cell Acute Lymphoblastic Leukemia
City of Hope Medical Center
City of Hope Medical Center
Institute of Hematology & Blood Diseases Hospital, China
Institute of Hematology & Blood Diseases Hospital, China
AstraZeneca
M.D. Anderson Cancer Center
Princess Maxima Center for Pediatric Oncology
The First Affiliated Hospital with Nanjing Medical University
Dalian Medical University
IRCCS San Raffaele
Israeli Medical Association